Potential role of matrix metalloproteinase-2,-9 and tissue inhibitors of metalloproteinase-1,-2 in exudative pleural effusions

Clinical and Investigative Medicine

Volumn 32, Issue 4, 2009, Pages

  Vatansever, S ^a   Gelisgen, R ^a   Uzun, Hafize ^a   Yurt, S ^b   Kosar, F ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Yedikule Teaching Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; LACTATE DEHYDROGENASE; PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXUDATIVE PLEURISY; FEMALE; HUMAN; MALE; MALIGNANT PLEURISY; PLEURA CANCER; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN DETERMINATION; THORACOCENTESIS; TUBERCULOUS PLEURISY;

ADOLESCENT; ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PLEURAL EFFUSION; PLEURISY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUBERCULOSIS, PLEURAL; YOUNG ADULT;

EID: 68049145907     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kroegel C, Antony VB. Immunobiology of pleural inflammation: potencial implications for pathogenesis, diagnosis and therapy. Eur Respir J. 1997;10:2411-2418
2. Heffner JE, Klein JS. Recent Advances in the Diagnosis and Management of Malignant Pleural Effusions. Mayo Clin Proc. 2008;83:235-250
3. Light RW. Pleural diseases. Dis. Mon 1992;38:261-331.
4. Sahn SA. State of the art. The pleura. Am. Rev. Respir. Dis. 1988;138:184-234.
5. Valdes L, San Jose E, Alvarez D, Valle JM. Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Respir J 1996;9:747-751
6. Lee YCG, Rogers JT, Rodriguez RM, Miller KD, Light RW. Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest 2001;120:356-361
7. Jimenez Castro D, Diaz Nuevo G, Perez-Rodriguez E, Light RW. Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions. Eur Respir J 2003;21:220-224
8. Chen ML, Yu WC, Lam CW, Au KM, Kong FY, Wo Cham AY. Diagnostic value of pleural fluid adenosine deaminase activity in tuberculous pleurisy. Clin Chim Acta 2004;341:101-107
9. Laniado-Laborin R. Adenosine deaminase in the diagnosis of tuberculous effusion. Is it really an ideal test? A word of caution. Chest 2005;127:417-418
10. Thrailkill KM, Clay Bunn R, Fowlkes JL. Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy. Endocrine. 2009;35:1-10.
11. Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H. Ann. Rheum. Dis 1989;48:645-653
12. Nagase H. Matrix Metalloproteinases. Taylor and Francis; London: 1996.
13. Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res 2001;2:10-19.
14. Silva JA, Lorencini M, Peroni LA, De La Hoz CL, Carvalho HF, Stach-Machado DR. The influence of type I diabetes mellitus on the expression and activity of gelatinases (matrix metalloproteinases-2 and -9) in induced periodontal disease. J Periodontal Res 2008;43:48-54.
15. O'Connor CM, FitzGerald MX. Matrix metalloproteases and lung disease. Thorax 1994;49:602-609
16. Eickelberg O, Sommerfeld CO, Wyser C, et al. MMP and TIMP expression pattern in pleural effusions of different origins. Am J Respir Crit Care Med 1997;156:1987-1992
17. Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusion: the diagnostic separation of transudates and exudates.. Ann Intern Med 1972; 77:507-513
18. Sahn S. State of the art: the pleura. Am Rev Respir Dis 1988;138:184-234.
19. Von Hoff D, Di Volsi V. Diagnostic reliability of needle biopsy of the parietal pleura: a review of 272 biopsies. Am J Clin Pathol 1979;72:48-51.
20. Schönfeld N, Loddenkemper R. Pleural biopsy and thoracoscopy. Eur Respir Mon 1998;9:135-152
21. Poe RH, Israel RH, Utell MJ, Hall WJ, Greenblatt DW, Kallay MC. Sensitivity, specificity and predictive values of closed pleural biopsy. Arch Intern Med 1984;144:325-328
22. Leung A, Muller N, Miller R. CT in differential diagnosis of diffuse pleural disease. Am J Roentgenol 1990;154:487-492
23. Sahn S. Malignant pleural effusions. In: Fischman AP, editor. Pulmonary diseases and disorders. 2nd ed. New York: Mc Graw- Hill; 1988. p. 2159-2170
24. Ruokolainen H, Pääkkö P, Turpeenniemi-Hujanen T. Tissue and circulating immunoreactive protein for MMP-2 and TIMP-2 in head and neck squamous cell carcinoma - tissue immunoreactivity predicts aggressive clinical course. Mod Pathol 2006;19:208-217
25. Kumaki F, Matsui K, Kawai T, et al. Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia. Am J Pathol 2001;159:2125-2135
26. Fassina G, Ferrari N, Brigati C, et al. Tissue inhibitors of metalloproteases: regulation and biological activities. Clin Exp Metastasis 2000;18:111-120
27. Jin HY, Lee KS, Jin SM, Lee YC. Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion. Respir Med. 2004;98:115-122
28. Hoheisel G, Sack U, Hui DS, et al. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis. Tuberculosis 2001;81:203-209
29. Hojilla CV, Mohammed FF, Khokha R. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 2003;89:1817-1821
30. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 1999;13:35-48.
31. Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999;43 Suppl:S42-51.
32. Eickelberg O, Sommerfeld CO, Wyser C, et al. MMP and TIMP expression pattern in pleural effusions of different origins. Am J Respir Crit Care Med 1997;156:1987-1992